Introduction to dementia, Cost-Benefit Analysis, and the new interventions

.

Chapter 1 in Cost-Benefit Analysis and Dementia, 2022, pp 2-17 from Edward Elgar Publishing

Abstract: Using the medical definition of dementia in terms of brain pathology is not useful at this time. Medical interventions that can alter brain pathology do not yet exist. Sticking to this medical definition would mean that, currently, nothing can be done to intervene to reduce dementia. By contrast, if we define dementia in terms of behavioural symptoms, as we do in this book, then there are interventions that already exist that are effective and worthwhile. This book is devoted to a presentation of five new, non-medical, worthwhile dementia interventions, and to explaining the ingredients that allow them to be classed as "worthwhile". In this chapter, we set out the fundamentals. This involves: defining what is dementia; identifying what are the types of intervention that have been tested; explaining what is necessary to establish effectiveness; and explaining the role of Cost-Benefit Analysis (CBA) in public policy decision-making related to dementia interventions.

Keywords: Development Studies; Economics and Finance; Environment; Sociology and Social Policy (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.elgaronline.com/view/9781839105753.00009.xml (application/pdf)
Our link check indicates that this URL is bad, the error code is: 503 Service Temporarily Unavailable

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:elg:eechap:19697_1

Ordering information: This item can be ordered from
http://www.e-elgar.com

Access Statistics for this chapter

More chapters in Chapters from Edward Elgar Publishing
Bibliographic data for series maintained by Darrel McCalla ().